Status: Not yet recruiting
A Study of GSM-779690T in Healthy Adult Participants
A Phase 1, single-centre, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of a single and multiple dose regimens of GSM-779690T in healthy adults. This first-in-human study will evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GSM-779690T.
Participants needed: 72
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Acta PharmaceuticalsUpdated: Jul 9, 2026Locations: 1
Eligibility criteria
Healthy and aged 18-55 years. [+11]